Stroke Imaging: Quantity, But is There Quality?
Stroke Imaging: Quantity, But is There Quality?
复制标题
中风影像:数量,但有质量吗?
DOI:
10.1097/mlr.0000000000000538
复制
发表时间:
2016
期刊:
影响因子:
3
通讯作者:
Burke,JamesF
中科院分区:
文献类型:
--
作者:
Levine,DeborahA;Burke,JamesF
Diagnostic tests are a routine part of clinical care, accounting for a considerable amount of clinical effort and costs. We commonly assess the quality of medical care by examining these processes of care rather than their outcomes. However, the evidence base for “good” medical care, even guideline-recommended care, is often less strong than we realize. 1 This is particularly true for diagnostic tests that only influence outcomes indirectly by changing decision making and management. 2 Thus, in routine clinical practice, fundamental questions go unasked or unanswered: Why do we test? Who should we test?These questions, although not unasked, are largely unanswered for most diagnostic tests for stroke. Every year, millions of individuals worldwide suffer a stroke, 80%–87% of which are ischemic. Clinical practice guidelines recommend several imaging tests for suspected or confirmed stroke and transient ischemic attack (TIA) including recommendations on axial brain imaging [eg, computed tomography (CT) or magnetic resonance imaging (MRI)], vascular (intracranial and cervical) imaging, and echocardiography. 3–5 However, these recommendations are based on modest and varying levels of evidence and expert opinion. Formal technology assessments of many recommended diagnostic tests for stroke are lacking.